Swing Therapeutics
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- $19M
Investors
- 8
About Swing Therapeutics
Swing Therapeutics, Inc., headquartered in San Francisco, California, specializes in creating digital therapies.Swing Therapeutics specializes in developing digital therapies aimed at improving the quality of life for individuals with chronic illnesses, particularly those suffering from fibromyalgia. Their flagship product, Stanza, is an FDA-cleared digital therapy designed specifically for the management of fibromyalgia symptoms. This therapy functions by delivering evidence-based behavioral treatments through a smartphone application, allowing users to engage in 15-minute sessions at their convenience. The primary end users are patients diagnosed with fibromyalgia, and the service is available by prescription, catering to individuals seeking non-pharmacological treatment options.Swing Therapeutics generates revenue primarily through the prescription of its digital therapy product, Stanza. The transaction model is direct-to-consumer, with patients accessing the therapy via their healthcare providers who prescribe the treatment based on individual needs. The company positions its service as a subscription-based offering, aimed at providing ongoing access to therapeutic content and support. Although specific pricing details are not disclosed, the structure implies a recurring revenue model where patients can engage with the therapy over an extended period. The company is focused on launching new products aimed at enhancing the therapeutic experience for users and is targeting expansion into European markets and other regions where chronic pain management solutions are needed. The additional capital will support these initiatives as the company seeks to grow its reach and effectiveness in addressing fibromyalgia and similar chronic conditions.
Who invested in Swing Therapeutics
8 investors across 2 rounds
See all investors in Swing Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Swing Therapeutics
Who invested in Swing Therapeutics?
Swing Therapeutics has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Swing Therapeutics raised?
Swing Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Swing Therapeutics last raise money?
Swing Therapeutics's most recent round on record is a Series A, in Jan 2022.
What does Swing Therapeutics do?
Swing Therapeutics is a biotechnology company.
Where is Swing Therapeutics headquartered?
Swing Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Swing Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Swing Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Swing Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.